Nutrition, Metabolism & Cardiovascular Diseases
Volume 20, Issue 2 , Pages 79-86 , February 2010

Measuring and estimating insulin resistance in clinical and research settings

Received 5 March 2009 ,Revised 26 July 2009 ,Accepted 27 July 2009.

References 

  1. Yalow R, Berson S. Immunoassay of endogenous plasma insulin in man. J Clin Invest. 1960;39:1157–1175
  2. Matsuda M, DeFronzo RA. In vivo measurement of insulin sensitivity in human clinical research in diabetes and obesity. In:  Draznin B,  Rizza R editor. Part I: methods, assessment, and metabolic regulation. (Totowa, NJ, USA): Humana Press; 1997;p. 23–65
  3. Ferrannini E, Mari A. How to measure insulin sensitivity. J Hypertens. 1998;16:895–906
  4. Radziuk J. Insulin sensitivity and its measurement: structural commonalities among the methods. J Clin Endocrinol Metab. 2000;85:4426–4433
  5. Muniyappa R, Lee S, Chen H, Quon MJ. Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage. Am J Physiol Endocrinol Metab. 2008;294:E15–E26
  6. Stumvoll M, Mitrakou A, Pimenta W, Jenssen T, Yki-Järvinen H, Van Haeften T, et al. Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity. Diabetes Care. 2000;23:295–301
  7. Matsuhisa M, Yamasaki Y, Emoto M, Shimabukuro M, Ueda S, Funahashi T, et al. A novel index of insulin resistance determined from the homeostasis model assessment index and adiponectin levels in Japanese subjects. Diabetes Res Clin Pract. 2007;77:151–154
  8. Turner RC, Holman RR, Matthews D, Hockaday TD, Peto J. Insulin deficiency and insulin resistance interaction in diabetes: estimation of their relative contribution by feedback analysis from basal plasma insulin and glucose concentrations. Metabolism. 1979;28:1086–1096
  9. DeFronzo RA, Tobin J, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Phys. 1979;237:E214–E223
  10. Bergman RN, Ider YZ, Bowden CR. Quantitative estimation of insulin sensitivity. Am J Physiol. 1979;236:E667–E677
  11. Bonora E, Capaldo B, Perin PC, Del Prato S, De Mattia G, Frittitta L, et al. Hyperinsulinemia and insulin resistance are independently associated with plasma lipids, uric acid and blood pressure in non-diabetic subjects. The GISIR database. Nutr Metab Cardiovasc Dis. 2008;18:624–631
  12. Galluzzo A, Amato MC, Giordano C. Insulin resistance and polycystic ovary syndrome. Nutr Metab Cardiovasc Dis. 2008;18:511–518
  13. Annuzzi G, Giacco R, Patti L, Di Marino L, De Natale C, Costabile G, et al. Postprandial chylomicrons and adipose tissue lipoprotein lipase are altered in type 2 diabetes independently of obesity and whole-body insulin resistance. Nutr Metab Cardiovasc Dis. 2008;18:531–538
  14. Bigazzi R, Bianchi S, Buoncristiani E, Campese VM. Increased cardiovascular events in hypertensive patients with insulin resistance: a 13-year follow-up. Nutr Metab Cardiovasc Dis. 2008;18:314–319
  15. Ferrannini E, Mari A. Beta cell function and its relation to insulin action in humans: a critical appraisal. Diabetologia. 2004;47:943–956
  16. Kahn SE, Prigeon RL, McCulloch DK, Boyko EJ, Bergman RN, Schwartz MW, et al. Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function. Diabetes. 1993;42:1663–1672
  17. Bergman RN, Phillips LS, Cobelli C. Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and beta-cell glucose sensitivity from the response to intravenous glucose. The quantitative contributions of pancreatic. J Clin Invest. 1981;68:1456–1467
  18. Gastaldelli A, Ferrannini E, Miyazaki Y, Matsuda M, Mari A, DeFronzo RA. Thiazolidinediones improve beta-cell function in type 2 diabetic patients. Am J Physiol Endocrinol Metab. 2007;292:E871–E883
  19. Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care. 1999;22:1462–1470
  20. Rizza RA, Mandarino LJ, Gerich JE. Dose-response characteristics for effects of insulin on production and utilization of glucose in man. Am J Physiol. 1981;240:E630–E639
  21. Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care. 2004;27:2282–2283
  22. Matsuda M, Lee N, Shank M, DeFronzo RA. Isolation of hepatic and peripheral insulin sensitivity: application to the investigation of inherited or acquired defects in NIDDM. Diabetes. 1996;45(Suppl. 1):17A
  23. Groop LC, Bonadonna RC, DelPrato S, Ratheiser K, Zyck K, Ferrannini E, et al. Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. Evidence for multiple sites of insulin resistance. J Clin Invest. 1989;84:205–213
  24. Matsuda M. Manual of plasma glucose management in the hospital – theory and practice. Tokyo, Japan: Kanehara & Co. Ltd.; 2008;[published in Japanese]. p. 1–137
  25. Matsuda M, Hisano Y, Hayakawa N, Shigeto M, Akiyama Y, Masuzawa M, et al. Difference between insulin sensitivity expressed by ability to lower plasma glucose concentration and to keep plasma glucose concentration stable during medical treatment. Diabetologia. 2008;51(Suppl. 1):S440
  26. Olefsky J, Farquhar JW, Reaven G. Relationship between fasting plasma insulin level and resistance to insulin-mediated glucose uptake in normal and diabetic subjects. Diabetes. 1973;22:507–513
  27. Levy JC, Matthews DR, Hermans MP. Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care. 1998;21:2191–2192
  28. Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G, et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab. 2000;85:2402–2410
  29. Hosker JP, Matthews DR, Rudenski AS, Burnett MA, Darling P, Bown EG, et al. Continuous infusion of glucose with model assessment: measurement of insulin resistance and beta-cell function in man. Diabetologia. 1985;28:401–411
  30. Levine R, Haft DE. Carbohydrate homeostasis. N Engl J Med. 1970;283:237–246
  31. Cederholm J, Wibell L. Insulin release and peripheral sensitivity at the oral glucose tolerance test. Diabetes Res Clin Pract. 1990;10:167–175
  32. Avignon A, Boegner C, Mariano-Goulart D, Colette C, Monnier L. Assessment of insulin sensitivity from plasma insulin and glucose in the fasting or post oral glucose-load state. Int J Obes Relat Metab Disord. 1999;23:512–517
  33. Mari A, Pacini G, Murphy E, Ludvik B, Nolan JJ. A model-based method for assessing insulin sensitivity from the oral glucose tolerance test. Diabetes Care. 2001;24:539–548
  34. Caumo A, Bergman RN, Cobelli C. Insulin sensitivity from meal tolerance tests in normal subjects: a minimal model index. J Clin Endocrinol Metab. 2000;85:4396–4402
  35. Breda E, Cavaghan MK, Toffolo G, Polonsky KS, Cobelli C. Oral glucose tolerance test minimal model indexes of beta-cell function and insulin sensitivity. Diabetes. 2001;50:150–158
  36. Bastard JP, Vandernotte JM, Faraj M, Karelis AD, Messier L, Malita FM, et al. Relationship between the hyperinsulinemic-euglycaemic clamp and a new simple index assessing insulin sensitivity in overweight and obese postmenopausal women. Diabetes Metab. 2007;33:261–268
  37. Abdul-Ghani MA, Matsuda M, Balas B, DeFronzo RA. Muscle and liver insulin resistance indexes derived from the oral glucose tolerance test. Diabetes Care. 2007;30:89–94
  38. Pillonetto G, Caumo A, Sparacino G, Cobelli C. A new dynamic index of insulin sensitivity. IEEE Trans Biomed Eng. 2006;53:369–379
  39. Himsworth HP. The mechanism of diabetes mellitus. Lancet. 1939;2:1–6
  40. Lundbaek K. Intravenous glucose tolerance as a tool in definition and diagnosis of diabetes mellitus. Br Med J. 1962;1:1507–1513
  41. Shen SW, Reaven GM, Farquhar JW, Shen SW, Reaven GM, Farquhar JW. Clin Investig. 1970;49:2151–2160
  42. Harano Y, Ohgaku S, Hidaka H, Haneda K, Kikkawa R, Shigeta Y, et al. Glucose, insulin and somatostatin infusion for the determination of insulin sensitivity. J Clin Endocrinol Metab. 1977;45:1124–1127
  43. Cerasi E, Luft R. The plasma insulin response to glucose infusion in healthy subjects and in diabetes mellitus. Acta Endocrinol (Copenh). 1967;55:278–304
  44. Johnston C, Ward WK, Beard JC, McKnight B, Porte D. Islet function and insulin sensitivity in the non-diabetic offspring of conjugal type 2 diabetic patients. Diabetes Med. 1990;7:119–125
  45. Zierler KL. Theory of the use of arteriovenous concentration differences for measuring metabolism in steady and non-steady state. J Clin Invest. 1961;40:2111–2125
  46. Matsuda M, Shigeto M, Akiyama Y, Masuzawa M, Okabe T. Constancy of relative insulin sensitivity and importance of absolute insulin sensitivity shift to develop insulin infusion protocol in critically ill patients. Diabetologia. 2007;50(Suppl. 1):S276–S277

PII: S0939-4753(09)00185-9

doi: 10.1016/j.numecd.2009.07.007

Nutrition, Metabolism & Cardiovascular Diseases
Volume 20, Issue 2 , Pages 79-86 , February 2010